Showing 141-150 of 1665 results for "".
Physician Spotlight With A. Yasmine Kirkorian, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-with-a-yasmine-kirkorian-md/23082/Harnessing the Power of Humor for Psoriasis
https://practicaldermatology.com/topics/psoriasis/harnessing-the-power-of-humor-for-psoriasis/23007/Humor can create positive changes in our thoughts, feelings, behaviors, and biochemistry and can also influence how patients cope.Take a Load Off Your Back: A How-To Guide
https://practicaldermatology.com/topics/practice-management/take-a-load-off-your-back-a-how-to-guide/22076/Dermatologic surgeons spend their days bent over exam tables to perform procedures. Their backs may suffer.The Gender Gap in Dermatology: Where Are We Now?
https://practicaldermatology.com/topics/general-topics/the-gender-gap-in-dermatology-where-are-we-now/20820/Despite advances, women are still not equally represented in academic dermatology or dermatology leadership.FDA Approvals, Acne Insights, EPI Gets Cloderm
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-fda-approvals-acne-insights-epi-gets-cloderm/18230/In a flurry of approvals, FDA gives the nod to Almirall's Seysara (sarecycline), Ortho Dermatologics' Bryhali (halobetasol propionate, 0.01%) Lotion, Paratek Pharmaceuticals' Nuzyra (omadacycline), and Regeneron's Libtayo (cemiplimab). Research shows top earners across various fields in the US mayA Review of Incident to Services
https://practicaldermatology.com/topics/practice-management/a-review-of-incident-to-services/20526/In order to ensure correct billing—and reimbursements—it is important to understand incident to policies.Content Marketing for Dermatologists
https://practicaldermatology.com/topics/practice-management/content-marketing-for-dermatologists/20536/A mix of time-sensitive and evergreen content is best to optimize engagement.Janssen Approvals, New Thermage FLX, Restylane Silk Cannulas
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-janssen-approvals-new-thermage-flx-restylane-silk-cannulas/18401/Janssen Biotech's Stelara is now approved for the treatment of adolescents 12 years of age or older with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Janssen's SIMPONI ARIA® cleared for the treatment of adults with active psoriatic arthritis or activeCreating An Enjoyable Experience
https://practicaldermatology.com/topics/practice-management/creating-an-enjoyable-experience/20732/How to establish a healthy practice culture that satisfies staff.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20924/